SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-017670
Filing Date
2022-05-04
Accepted
2022-05-04 07:30:53
Documents
52
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20220331.htm   iXBRL 10-Q 878150
2 EX-31.1 nerv-ex311_7.htm EX-31.1 20370
3 EX-31.2 nerv-ex312_10.htm EX-31.2 19982
4 EX-32.1 nerv-ex321_6.htm EX-32.1 10586
  Complete submission text file 0001564590-22-017670.txt   3670497

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nerv-20220331.xsd EX-101.SCH 36302
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20220331_cal.xml EX-101.CAL 25716
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20220331_def.xml EX-101.DEF 100526
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20220331_lab.xml EX-101.LAB 265226
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20220331_pre.xml EX-101.PRE 201102
46 EXTRACTED XBRL INSTANCE DOCUMENT nerv-10q_20220331_htm.xml XML 488589
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 22889836
SIC: 2834 Pharmaceutical Preparations